chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Malaise
Clinical narrative: Strong dizziness/ dizzy, sometime more, sometimes less; do not feel well; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Feb2021 at 15:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension benign. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), estradiol (MANUFACTURER UNKNOWN) and calcium citrate (CITRACAL); all for unknown indication from an unknown date and unknown if ongoing. On 02Feb2021 at 07:00, next day after vaccination when the patient woke up, experienced strong dizziness. Since then, the patient did not feel well and was dizzy, sometime more, sometimes less. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong dizziness, did not feel well and was dizzy was not recovered at the time of this report. The patient also received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Feb2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Blood glucose increased, Dizziness
Clinical narrative: Dizziness; Equilibrium issues; Abnormal spike in blood sugar levels; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetic and Crohns. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN), mercaptopurine (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN) and pioglitazone (MANUFACTURER UNKNOWN), all for unknown indication from unknown dates and unknown if ongoing. On 03Mar2021 at 20:30, the patient experienced dizziness, equilibrium issues 35 hours after vaccination and abnormal spike in blood sugar levels the next day. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events dizziness, equilibrium issues and abnormal spike in blood sugar levels was recovered on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Blood glucose, Blood glucose increased, Dizziness
Clinical narrative: Dizziness; Equilibrium issues; Abnormal spike in blood sugar levels; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetic and Crohns. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included metformin (MANUFACTURER UNKNOWN), mercaptopurine (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN) and pioglitazone (MANUFACTURER UNKNOWN), all for unknown indication from unknown dates and unknown if ongoing. On 03Mar2021 at 20:30, the patient experienced dizziness, equilibrium issues 35 hours after vaccination and abnormal spike in blood sugar levels the next day. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events dizziness, equilibrium issues and abnormal spike in blood sugar levels was recovered on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash maculo-papular
Clinical narrative: Maculopapular rash on abdomen, chest, sides, back, and underside of side of arms; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 02Mar2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included peripheral neuropathy, heart arrhythmia and mixed connective tissue disease (MCTD). The patient had allergy to wasp stings. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and hydroxychloroquine (PLAQUENIL); both from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9268) via an unspecified route of administration in the left arm on 08Feb2021 at 10:15 as a single dose for COVID-19 immunisation. On 02Mar2021 at 16:00, the patient experienced maculopapular rash on abdomen, chest, sides, back and underside of side of arms. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of the events included treatment with antihistamine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event maculopapular rash on abdomen, chest, sides, back, and underside of side of arms was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Fatigue, Headache, Injection site swelling, Localised oedema
Clinical narrative: right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up; chest and abdomen all swelled up; abdomen all swelled up; enlarged lymph nodes in the left arm, right arm and abdomen; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in right arm on 01Mar2021 at 08:30 (age at vaccination was 68-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included double mastectomy on Jun2017, asthma, severe allergies; and allergy to latex, sulfa, gadolinium and iodine. Concomitant medications received within 2 weeks included cetirizine hydrochloride (ZYRTEC), ergocalciferol (VIT D), omeprazole (PRILOSEC),tamoxifen and multivitamin; all from an unspecified date and unknown indication. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up on 01Mar2021 at 12:30; and enlarged lymph nodes in the left arm, right arm and abdomen on Mar2021. It was further reported that 4 hours after her injection, her right arm (injection site), chest and abdomen all swelled up. On 02Mar2021, allergist told the patient to take diphenhydramine (BENADRYL) for two days. On 10Mar2021, primary care doctor thought the patient had a blood clot because patient was so swollen. He ordered a STAT ultrasound of right arm and CT of abdomen and report stated enlarged lymph nodes in the left arm, right arm and abdomen. On 23Mar2021, the patient had blood drawn in right arm then arm immediately swelled up. On 24Mar2021, the primary care said that he would contact CDC as they can't figure out the swelling. On 26Mar2021, the patient saw an oncologist who also did not know what was causing the swelling. All doctors and radiologist agree that this was after the COVID-19 immunization. It was reported that the patient's arms and abdomen were still swollen. The patient underwent lab tests and procedures which included blood drawn (blood test) with unknown results on 23Mar2021; STAT ultrasound of right arm and CT of abdomen with both result of 'enlarged lymph nodes in the left arm, right arm and abdomen' on Mar2021. The events resulted to physician office visit. Therapeutic measures were taken as a result of right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up  included diphenhydramine while no treatment received for other reported events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oedema peripheral, Pain, Peripheral swelling
Clinical narrative: right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up; chest and abdomen all swelled up; abdomen all swelled up; enlarged lymph nodes in the left arm, right arm and abdomen; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in right arm on 01Mar2021 at 08:30 (age at vaccination was 68-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included double mastectomy on Jun2017, asthma, severe allergies; and allergy to latex, sulfa, gadolinium and iodine. Concomitant medications received within 2 weeks included cetirizine hydrochloride (ZYRTEC), ergocalciferol (VIT D), omeprazole (PRILOSEC),tamoxifen and multivitamin; all from an unspecified date and unknown indication. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up on 01Mar2021 at 12:30; and enlarged lymph nodes in the left arm, right arm and abdomen on Mar2021. It was further reported that 4 hours after her injection, her right arm (injection site), chest and abdomen all swelled up. On 02Mar2021, allergist told the patient to take diphenhydramine (BENADRYL) for two days. On 10Mar2021, primary care doctor thought the patient had a blood clot because patient was so swollen. He ordered a STAT ultrasound of right arm and CT of abdomen and report stated enlarged lymph nodes in the left arm, right arm and abdomen. On 23Mar2021, the patient had blood drawn in right arm then arm immediately swelled up. On 24Mar2021, the primary care said that he would contact CDC as they can't figure out the swelling. On 26Mar2021, the patient saw an oncologist who also did not know what was causing the swelling. All doctors and radiologist agree that this was after the COVID-19 immunization. It was reported that the patient's arms and abdomen were still swollen. The patient underwent lab tests and procedures which included blood drawn (blood test) with unknown results on 23Mar2021; STAT ultrasound of right arm and CT of abdomen with both result of 'enlarged lymph nodes in the left arm, right arm and abdomen' on Mar2021. The events resulted to physician office visit. Therapeutic measures were taken as a result of right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up  included diphenhydramine while no treatment received for other reported events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Blood test, Computerised tomogram, Lymphadenopathy, Swelling
Clinical narrative: right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up; chest and abdomen all swelled up; abdomen all swelled up; enlarged lymph nodes in the left arm, right arm and abdomen; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in right arm on 01Mar2021 at 08:30 (age at vaccination was 68-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included double mastectomy on Jun2017, asthma, severe allergies; and allergy to latex, sulfa, gadolinium and iodine. Concomitant medications received within 2 weeks included cetirizine hydrochloride (ZYRTEC), ergocalciferol (VIT D), omeprazole (PRILOSEC),tamoxifen and multivitamin; all from an unspecified date and unknown indication. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up on 01Mar2021 at 12:30; and enlarged lymph nodes in the left arm, right arm and abdomen on Mar2021. It was further reported that 4 hours after her injection, her right arm (injection site), chest and abdomen all swelled up. On 02Mar2021, allergist told the patient to take diphenhydramine (BENADRYL) for two days. On 10Mar2021, primary care doctor thought the patient had a blood clot because patient was so swollen. He ordered a STAT ultrasound of right arm and CT of abdomen and report stated enlarged lymph nodes in the left arm, right arm and abdomen. On 23Mar2021, the patient had blood drawn in right arm then arm immediately swelled up. On 24Mar2021, the primary care said that he would contact CDC as they can't figure out the swelling. On 26Mar2021, the patient saw an oncologist who also did not know what was causing the swelling. All doctors and radiologist agree that this was after the COVID-19 immunization. It was reported that the patient's arms and abdomen were still swollen. The patient underwent lab tests and procedures which included blood drawn (blood test) with unknown results on 23Mar2021; STAT ultrasound of right arm and CT of abdomen with both result of 'enlarged lymph nodes in the left arm, right arm and abdomen' on Mar2021. The events resulted to physician office visit. Therapeutic measures were taken as a result of right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up  included diphenhydramine while no treatment received for other reported events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan, Vaccination site swelling
Clinical narrative: right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up; chest and abdomen all swelled up; abdomen all swelled up; enlarged lymph nodes in the left arm, right arm and abdomen; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in right arm on 01Mar2021 at 08:30 (age at vaccination was 68-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included double mastectomy on Jun2017, asthma, severe allergies; and allergy to latex, sulfa, gadolinium and iodine. Concomitant medications received within 2 weeks included cetirizine hydrochloride (ZYRTEC), ergocalciferol (VIT D), omeprazole (PRILOSEC),tamoxifen and multivitamin; all from an unspecified date and unknown indication. The patient previously took ciprofloxacin (CIPRO) and experienced drug allergy. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient experienced right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up on 01Mar2021 at 12:30; and enlarged lymph nodes in the left arm, right arm and abdomen on Mar2021. It was further reported that 4 hours after her injection, her right arm (injection site), chest and abdomen all swelled up. On 02Mar2021, allergist told the patient to take diphenhydramine (BENADRYL) for two days. On 10Mar2021, primary care doctor thought the patient had a blood clot because patient was so swollen. He ordered a STAT ultrasound of right arm and CT of abdomen and report stated enlarged lymph nodes in the left arm, right arm and abdomen. On 23Mar2021, the patient had blood drawn in right arm then arm immediately swelled up. On 24Mar2021, the primary care said that he would contact CDC as they can't figure out the swelling. On 26Mar2021, the patient saw an oncologist who also did not know what was causing the swelling. All doctors and radiologist agree that this was after the COVID-19 immunization. It was reported that the patient's arms and abdomen were still swollen. The patient underwent lab tests and procedures which included blood drawn (blood test) with unknown results on 23Mar2021; STAT ultrasound of right arm and CT of abdomen with both result of 'enlarged lymph nodes in the left arm, right arm and abdomen' on Mar2021. The events resulted to physician office visit. Therapeutic measures were taken as a result of right arm (injection site), chest and abdomen all swelled up / arm immediately swelled up  included diphenhydramine while no treatment received for other reported events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 01Mar2021 at 12:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that the patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021 at 12:15, 15 minutes after the vaccination, the patient experienced ringing in ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in ears was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Ears are ringing almost as if someone is blowing a whistle constantly or as if there are 5 TV's turned on. The high pitch is occurring in the 15,000kHz to 17,000kHz range and will not stop.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 08:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to apples, grass and pollen. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 09:00, 24 hours after the first dose, the patient experienced that his ears were ringing almost as if someone was blowing a whistle constantly or as if there were 5 TV's turned on. The high pitch was occurring in the 15,000kHz to 17,000kHz range and would not stop and had been continuing for 2 full days. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears were ringing was not recovered at the time of this report.   No follow-up attempts are required; information about lot number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Myalgia
Clinical narrative: Back muscle pain from neck to waist; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6230) via an unspecified route of administration in the right  arm on 28Feb2021 at 09:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and the patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), bupropion hydrochloride (BUPROPION HCL XL), both were for an unknown indication, from an unknown date and unknown if ongoing. On 28Feb2021 at 10:30, 1 hour after vaccination the patient experienced back muscle pain from neck to waist and 8 days lasted with the pain staying the same. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event back muscle pain from neck to waist was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain
Clinical narrative: Back muscle pain from neck to waist; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6230) via an unspecified route of administration in the right  arm on 28Feb2021 at 09:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and the patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), bupropion hydrochloride (BUPROPION HCL XL), both were for an unknown indication, from an unknown date and unknown if ongoing. On 28Feb2021 at 10:30, 1 hour after vaccination the patient experienced back muscle pain from neck to waist and 8 days lasted with the pain staying the same. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event back muscle pain from neck to waist was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Vertigo
Clinical narrative: Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 20Feb2021 at 16:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal) (reported as periodic acid reflux) and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), ascorbic acid (VIT C), ergocalciferol (VIT D) and vitamin b (MANUFACTURER UNKNOWN); all for an unknown indication, from an unknown date and unknown if ongoing. On an unknown date, the patient was performing a yoga exercise as she did many times in the past, the patient could not lift head without feeling like she would pass out, called 911 and went to emergency room. On an unknown date, the patient underwent computerized axial tomography scan (CAT scan) with dye, blood test (blood work) and electrocardiogram (EKG) and the result was vertigo. On 02Mar2021 at 10:00, the patient was diagnosed with vertigo. The event vertigo resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient saw family doctor afterwards. Therapeutic measures were taken as a result of the event vertigo which included treatment with Epley maneuver. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes above left clavicle; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the left arm on 24Feb2021 at 10:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer and high blood pressure. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), chlortalidone (MANUFACTURER UNKNOWN) and omeprazole (PRILOSEC) all for unknown indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Mar2021, the patient experienced swollen lymph nodes above left clavicle. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event swollen lymph nodes above left clavicle was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6200), at the age of 30, via an unspecified route of administration, in the left arm, on Mar 3, 2021, at 15:30, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 5, 2021, at 09:00, patient experienced swollen lymph node in left armpit (injection arm). The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures taken as a result of the reported event. Since the vaccination, patient has not tested for COVID-19. The outcome of swollen lymph node in left armpit (injection arm) recovered on an unknown date in Mar 2021. No follow-up attempts needed. No further information expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Skin warm
Clinical narrative: "I" have a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obsessive compulsive disorder, hypertension and hyperuricemia. The patient had known allergy only to pollens and mold. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other unspecified concomitant medications. On 27Feb2021 at 20:30, the patient experienced a red area around the injection site. It was oval-shaped and 3 inches long by 1 1/2 inches wide. It was reported that, this had been there since he got the injection and does not seem to had gotten any smaller despite and this being the 10th day after the vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event the patient had a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site erythema
Clinical narrative: "I" have a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, obsessive compulsive disorder, hypertension and hyperuricemia. The patient had known allergy only to pollens and mold. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other unspecified concomitant medications. On 27Feb2021 at 20:30, the patient experienced a red area around the injection site. It was oval-shaped and 3 inches long by 1 1/2 inches wide. It was reported that, this had been there since he got the injection and does not seem to had gotten any smaller despite and this being the 10th day after the vaccination. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event the patient had a red area around the injection site, oval-shaped and 3 inches long by 1 1/2 inches wide was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chromaturia, Nausea
Clinical narrative: woke up three hours after going to sleep with intense upset stomach; Nausea; Cold sweat; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 11:15 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included lactose intolerance (allergy). The patient previously received codeine-based medications for an unknown indication from an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 08Mar2021, at 23:30 the patient woke up three hours after going to sleep with intense upset stomach, nausea and cold sweat. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense upset stomach, nausea and cold sweat was recovered on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Cold sweat, Nausea
Clinical narrative: woke up three hours after going to sleep with intense upset stomach; Nausea; Cold sweat; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 11:15 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included lactose intolerance (allergy). The patient previously received codeine-based medications for an unknown indication from an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 08Mar2021, at 23:30 the patient woke up three hours after going to sleep with intense upset stomach, nausea and cold sweat. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense upset stomach, nausea and cold sweat was recovered on an unknown date in Mar2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Sudden nausea at 12:15pm today almost 24 hours later and urgent vomiting.; Sudden nausea at 12:15pm today almost 24 hours later and urgent vomiting.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension controlled with medicine daily for 8 years from 2013, allergy to pork, eggplant, cucumber, bees, wasps, midge flies. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for hypertension taken daily from 2013 for 8 years. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced sudden nausea on 11Mar2021 at 12:15, the day of report almost 24 hours later and urgent vomiting. Therapeutic measures were taken as a result of nausea and sudden vomiting and included treatment with ingestion of two hard ginger candies. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sudden nausea at 12:15 on the day of report almost 24 hours later and urgent vomiting was resolved on 11Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swollen tongue, Vaccine positive rechallenge
Clinical narrative: Tongue swelling; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included liver transplant from an unknown date. The patient's concomitant medications were not reported.  Patient claims she did not get any antibodies after the first two doses of Pfizer BioNTech Covid-19 Vaccine. Her transplant team wants her to get a third dose of the Pfizer BioNTech Covid-19 Vaccine, but she is apprehensive because she experienced swelling of her tongue after both of her previous doses. She states the swelling was worse after the second dose than the first dose and she is concerned it could be even worse after a third dose. She is apprehensive. The second shot was worse than the first and she knows that allergy type reactions are worse than the time before. With the first shot, her tongue swelled up a bit. She took Benadryl before her second shot and her tongue swelled up more with the second shot. She is going to be going to the public health department shortly and would prefer to be transferred for her question. The outcome of the event was not recovered  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flushing, Swollen tongue
Clinical narrative: Tongue swelling; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included liver transplant from an unknown date. The patient's concomitant medications were not reported.  Patient claims she did not get any antibodies after the first two doses of Pfizer BioNTech Covid-19 Vaccine. Her transplant team wants her to get a third dose of the Pfizer BioNTech Covid-19 Vaccine, but she is apprehensive because she experienced swelling of her tongue after both of her previous doses. She states the swelling was worse after the second dose than the first dose and she is concerned it could be even worse after a third dose. She is apprehensive. The second shot was worse than the first and she knows that allergy type reactions are worse than the time before. With the first shot, her tongue swelled up a bit. She took Benadryl before her second shot and her tongue swelled up more with the second shot. She is going to be going to the public health department shortly and would prefer to be transferred for her question. The outcome of the event was not recovered  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Tongue swelling; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included liver transplant from an unknown date. The patient's concomitant medications were not reported.  Patient claims she did not get any antibodies after the first two doses of Pfizer BioNTech Covid-19 Vaccine. Her transplant team wants her to get a third dose of the Pfizer BioNTech Covid-19 Vaccine, but she is apprehensive because she experienced swelling of her tongue after both of her previous doses. She states the swelling was worse after the second dose than the first dose and she is concerned it could be even worse after a third dose. She is apprehensive. The second shot was worse than the first and she knows that allergy type reactions are worse than the time before. With the first shot, her tongue swelled up a bit. She took Benadryl before her second shot and her tongue swelled up more with the second shot. She is going to be going to the public health department shortly and would prefer to be transferred for her question. The outcome of the event was not recovered  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Pain
Clinical narrative: Chills; Body aches; Tiredness; Swollen lymph nodes in right armpit; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 09Mar2021 at 17:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included Postsurgical hypothyroidism, hypocalcemia, polycystic ovarian syndrome (PCOS), penicillin allergy and sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks, prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), escitalopram oxalate (LEXAPRO), metformin (MANUFACTURER UNKNOWN), calcitriol (MANUFACTURER UNKNOWN) and calcium citrate (CALCITRATE); all for an unknown indication, from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 16Feb2021 at 13:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 10Mar2021 at 11:30, the patient experienced chills, body aches, tiredness, swollen lymph nodes in right armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, body aches, tiredness, swollen lymph nodes in right armpit was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site rash, Rash pruritic
Clinical narrative: itchy rash on the arm around the site of injection; itchy rash on the arm around the site of injection; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 09Mar2021 at 09.45 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6201) via an unspecified route of administration in the left arm on 13Feb2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 11Mar2021, the patient experienced itchy rash on the arm around the site of injection. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy rash on the arm around the site of injection was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.